These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10681527)

  • 1. Identification and characterization of a PDZ protein that interacts with activin type II receptors.
    Shoji H; Tsuchida K; Kishi H; Yamakawa N; Matsuzaki T; Liu Z; Nakamura T; Sugino H
    J Biol Chem; 2000 Feb; 275(8):5485-92. PubMed ID: 10681527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.
    Liu ZH; Tsuchida K; Matsuzaki T; Bao YL; Kurisaki A; Sugino H
    J Endocrinol; 2006 May; 189(2):409-21. PubMed ID: 16648306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway.
    Matsuzaki T; Hanai S; Kishi H; Liu Z; Bao Y; Kikuchi A; Tsuchida K; Sugino H
    J Biol Chem; 2002 May; 277(21):19008-18. PubMed ID: 11882656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X; Nagarajan RP; Vale W; Chen Y
    FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localisation and role of activin receptor-interacting protein 1 in mouse brain.
    Liu HY; Wang YN; Ge JY; Li N; Cui XL; Liu ZH
    J Neuroendocrinol; 2013 Jan; 25(1):87-95. PubMed ID: 22849377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular and extracellular control of activin function by novel regulatory molecules.
    Tsuchida K; Matsuzaki T; Yamakawa N; Liu Z; Sugino H
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):25-31. PubMed ID: 11451568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.
    Lux A; Beil C; Majety M; Barron S; Gallione CJ; Kuhn HM; Berg JN; Kioschis P; Marchuk DA; Hafner M
    J Biol Chem; 2005 Mar; 280(9):8482-93. PubMed ID: 15611116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells.
    Qi Y; Ge JY; Wang YN; Liu HY; Li YM; Liu ZH; Cui XL
    Neurosci Lett; 2013 May; 542():53-8. PubMed ID: 23523645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RIM/NIM family of neuronal C2 domain proteins. Interactions with Rab3 and a new class of Src homology 3 domain proteins.
    Wang Y; Sugita S; Sudhof TC
    J Biol Chem; 2000 Jun; 275(26):20033-44. PubMed ID: 10748113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
    Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
    Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
    Nagarajan RP; Liu J; Chen Y
    J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three isoforms of synaptic scaffolding molecule and their characterization. Multimerization between the isoforms and their interaction with N-methyl-D-aspartate receptors and SAP90/PSD-95-associated protein.
    Hirao K; Hata Y; Yao I; Deguchi M; Kawabe H; Mizoguchi A; Takai Y
    J Biol Chem; 2000 Jan; 275(4):2966-72. PubMed ID: 10644767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
    Tsuchida K; Mathews LS; Vale WW
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11242-6. PubMed ID: 8248234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
    J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC.
    Blobe GC; Liu X; Fang SJ; How T; Lodish HF
    J Biol Chem; 2001 Oct; 276(43):39608-17. PubMed ID: 11546783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T; Moustakas A; Lin HY; Lodish HF
    Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.